Eptifibatide fumarate represents a crucial clinical intervention in cardiology, primarily employed to manage severe coronary conditions. This review delves into its mechanism of operation, focusing on the drug's potent ability to block platelet aggregation, hence reducing the risk of clotting complications. We intend explore studies examining the d